Nifty Pharma Stocks List
19 stocks · Data as of 9 Nov 2026
The Nifty Pharma table below lists 19 companies. The five largest by market capitalisation are Sun Pharmaceutical Industries Limited, Divi's Laboratories Limited, Torrent Pharmaceuticals Limited, Laurus Labs Limited and Zydus Lifesciences Limited, at closing prices on 9 Nov 2026.
The Nifty Pharma index tracks NSE-listed pharmaceutical companies — generic and specialty drug makers, API producers and contract manufacturers, many with large US and European businesses.
Every constituent is listed with its latest close, market capitalisation, valuation and quality score, sorted largest first.
| # | Symbol | Company | Sector | Price (₹) | Market Cap (₹ Cr) | P/E | Div. Yield (%) | ROCE (%) | Piotroski | vs 52W High (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | Sun Pharmaceutical Industries Limited | Healthcare | ₹1,904.5 | 4,56,953 | 39.84 | 0.93% | 15.73% | 4/9 | -6.96% |
| 2 | DIVISLAB | Divi's Laboratories Limited | Healthcare | ₹11,565.5 | 3,07,028 | 119.54 | 0.50% | 16.55% | 3/9 | -2.19% |
| 3 | TORNTPHARM | Torrent Pharmaceuticals Limited | Healthcare | ₹4,780 | 1,81,816 | 74.78 | 0.90% | 9.62% | 2/9 | -8.95% |
| 4 | LAURUSLABS | Laurus Labs Limited | Healthcare | ₹2,454 | 1,32,593 | 149 | 0.16% | 18.87% | 5/9 | -1.05% |
| 5 | ZYDUSLIFE | Zydus Lifesciences Limited | Healthcare | ₹1,215.9 | 1,21,287 | 24.27 | 1.26% | 15.77% | 5/9 | -4.00% |
| 6 | DRREDDY | Dr. Reddy's Laboratories Limited | Healthcare | ₹1,385 | 1,15,363 | 26.9 | 0.64% | 11.28% | 7/9 | -2.11% |
| 7 | CIPLA | Cipla Limited | Healthcare | ₹1,403.8 | 1,13,409 | 29.23 | 1.31% | 13.29% | 4/9 | -8.83% |
| 8 | MANKIND | Mankind Pharma Limited | Healthcare | ₹2,668.3 | 1,10,213 | 57.57 | 0.05% | 12.66% | 6/9 | -1.36% |
| 9 | AUROPHARMA | Aurobindo Pharma Limited | Healthcare | ₹1,855.3 | 1,06,750 | 30.75 | 0.31% | 12.55% | 6/9 | -0.04% |
| 10 | LUPIN | Lupin Limited | Healthcare | ₹2,025 | 92,601 | 17.34 | 0.52% | 26.82% | 4/9 | -19.94% |
| 11 | GLENMARK | Glenmark Pharmaceuticals Limited | Healthcare | ₹2,671.1 | 75,385 | 55.35 | 0.23% | 29.55% | 7/9 | -1.58% |
| 12 | ALKEM | Alkem Laboratories Limited | Healthcare | ₹5,398.5 | 64,547 | 28.04 | 0.97% | 16.30% | 3/9 | -9.02% |
| 13 | BIOCON | Biocon Limited | Healthcare | ₹368.5 | 60,002 | 130.67 | 0.18% | 3.02% | 5/9 | -17.59% |
| 14 | ABBOTINDIA | Abbott India Limited | Healthcare | ₹26,665 | 56,661 | 36.51 | 1.83% | 36.50% | 4/9 | -13.02% |
| 15 | GLAND | Gland Pharma Limited | Healthcare | ₹3,285 | 54,206 | 52.69 | 1.06% | 11.06% | 5/9 | -2.64% |
| 16 | IPCALAB | Ipca Laboratories Limited | Healthcare | ₹1,960 | 49,726 | 43.57 | 0.13% | 23.17% | 7/9 | -3.80% |
| 17 | AJANTPHARM | Ajanta Pharma Limited | Healthcare | ₹3,345.5 | 41,805 | 39.58 | 1.00% | 27.95% | 5/9 | -11.87% |
| 18 | WOCKPHARMA | Wockhardt Limited | Healthcare | ₹2,032 | 33,017 | 154.88 | 0.00% | 5.76% | 5/9 | -16.11% |
| 19 | PPLPHARMA | Piramal Pharma Limited | Healthcare | ₹245.3 | 32,529 | — | 0.10% | 0.68% | 2/9 | -2.04% |
Methodology: Constituents from the index provider's published membership, matched to the InvestSights screening dataset. Sorted by market capitalisation.
Frequently asked questions
How many stocks are in the Nifty Pharma?
The table lists 19 constituents of the Nifty Pharma as of 9 Nov 2026. Index membership is reviewed periodically by the index provider, so the count and the names can change at each rebalance.
Which is the largest company in the Nifty Pharma?
By market capitalisation the largest constituent in the current table is Sun Pharmaceutical Industries Limited, followed by Divi's Laboratories Limited, Torrent Pharmaceuticals Limited. The index provider weights constituents by free float, so the official index weight can differ from this plain market-cap ranking.
How often is this list updated?
The table is rebuilt from the InvestSights database on every visit. Prices and 52-week ranges update after each trading day's close; fundamentals update as companies file results. The date shown at the top is the price date the table reflects — currently 9 Nov 2026.
Is this a recommendation to buy these stocks?
No. This page is a factual list built from published market data and filings. It does not rate, rank for suitability, or recommend any security. InvestSights is not a SEBI-registered Research Analyst or Investment Adviser.
Related: All stock lists · Stock screener · Methodology & data sourcing
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.